Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia

NCT06368323 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-17

No results posted yet for this study

Summary

The goal of this randomized controled trial is to test the effects of assigning people with chronic post-stroke aphasia to 12 weekly choir sessions, compared to usual care.

The main question it aims to answer is:

Does the assignment to a choir singing program causes a beneficial effect on functional communication and language recovery as well as psychosocial outcomes compared to usual care in the rehabilitation of people with chronic post-stroke aphasia?

Participants will have:

12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master, and home singing training (3 x 30-minutes-sessions/week, total 18h)

Conditions

  • Aphasia

Interventions

BEHAVIORAL

Choir singing

The 12-week intervention will consist of 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master in addition to home training (3 x 30-minutes-sessions/week, total 18h). In total, participants will undergo the intervention for 3 hours/week for 12 weeks (i.e., 36 hours).

OTHER

Usual care

Rehabilitation services received by patients and social activities will be monitored and documented.

Sponsors & Collaborators

  • Toronto Metropolitan University

    collaborator OTHER
  • Université de Montréal

    collaborator OTHER
  • Université du Québec à Trois-Rivières

    collaborator OTHER
  • University of South Florida

    collaborator OTHER
  • University of Ottawa

    lead OTHER

Principal Investigators

  • Anna Zumbansen, PhD · University of Ottawa

  • Arla Good, PhD · Toronto Metropolitan University

  • Frank Russo, PhD · Toronto Metropolitan University

  • Carole Anglade, PhD · Université de Montréal

  • Édith Durand, PhD · Université du Québec à Trois-Rivières

  • Jennifer Bugos, PhD · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-22
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06368323 on ClinicalTrials.gov